Duality Advisers’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,335
Closed -$943K 812
2022
Q4
$943K Sell
7,335
-31,040
-81% -$4.01M 0.11% 327
2022
Q3
$5.25M Buy
+38,375
New +$6.25M 0.57% 18
2022
Q2
Sell
-2,990
Closed -$431K 914
2022
Q1
$431K Sell
2,990
-24,404
-89% -$3.3M 0.05% 500
2021
Q4
$4.24M Buy
+27,394
New +$4.59M 0.46% 53
2021
Q3
Sell
-22,920
Closed -$3.62M 739
2021
Q2
$3.62M Buy
22,920
+15,202
+197% +$2.26M 0.32% 96
2021
Q1
$1.07M Sell
7,718
-4,370
-36% -$704K 0.09% 340
2020
Q4
$2.12M Buy
+12,088
New +$2.25M 0.16% 200

Other funds holding SGEN

Duality Advisers's SGEN Position: Q1 2023 in Review

Duality Advisers sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 7,335 shares — an estimated $943K sold.

Duality Advisers first reported a position in SGEN in Q4 2020 and held it in 7 quarters. The position peaked at $5.25M in Q3 2022. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

  • Duality Advisers reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Duality Advisers sold 7,335 Seagen Inc. Common Stock shares in Q1 2023, an estimated $943K.
  • Duality Advisers first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Duality Advisers's Seagen Inc. Common Stock position peaked at $5.25M in Q3 2022.
  • 575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on Duality Advisers's 13F filing for Q1 2023, filed 27 Jun 2023.